← Back to Search

Behavioural Intervention

Exercise Program for Chronic Kidney Disease

N/A

Waitlist Available

Led By Devika Nair, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants classified as pre-frail per Fried Frailty phenotype due to slowness (time taken to walk 15 feet is greater than 6 seconds) in Aim 1

Participants who report 'YES' to any of the following: 'For health or physical reasons, do you have difficulty in walking a mile (5-6 blocks)?', 'If no, have you changed the way you walk half a mile (5-6 blocks) because of underlying health problems?', 'For health or physical reasons, do you have difficulty in climbing 1 flight of stairs (10 steps)?', 'If no, have you changed the way you climb 1 flight of stairs (10 steps) because of health problems?'

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 months, 6 months, and 7 months

Awards & highlights

Study Summary

This trial tests a 16-week exercise program for Veterans with advanced kidney disease to see if it is safe and tolerable.

Who is the study for?

This trial is for Veterans with advanced chronic kidney disease who experience difficulty walking or climbing stairs, and are considered pre-frail. They must be cleared by their doctor to participate, not wheelchair-bound, living outside long-term care facilities, not facing terminal illness or major surgery soon, and not enrolled in other exercise programs.Check my eligibility

What is being tested?

The study tests a 16-week physical activity and power training program's tolerability among participants. It involves two groups: one receiving the Pro-social Power Training Activity and another undergoing an Attention Control condition as a comparison.See study design

What are the potential side effects?

Since this is a physical activity program designed for individuals with chronic kidney disease, potential side effects may include muscle soreness, fatigue, joint pain or discomfort during or after exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am considered pre-frail because it takes me more than 6 seconds to walk 15 feet.

Select...

I have trouble walking a mile or climbing stairs due to health issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 months, 6 months, and 7 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 months, 6 months, and 7 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months, 6 months, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility, as measured by a numerical percentage of all participants who consented out of those eligible

Feasibility, as measured by a qualitative description of participants' reasons for declining

Feasibility, as measured by the questionnaire, the Feasibility of Intervention Measure

Other outcome measures

Acceptability, as measured by participants' qualitative descriptions of reasons for intervention enjoyability, if applicable

Acceptability, as measured by the questionnaire, the Acceptability of Intervention Measure

Adverse events, as measured by the the number of participants who report adverse events from the Common Terminology Criteria for Adverse Events, v5.0

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Power training and monitored physical activityExperimental Treatment1 Intervention

This is a 16-week power-training and physical activity-focused intervention that contains in-center and at-home components and motivational coaching. Participants will meet 2-3 times per week for the in-center power training. Participants will also be asked to wear accelerometers at home in order for their physical activity frequency to be measured.

Group II: Attention controlActive Control1 Intervention

This will be the attention control arm that will involve receipt of a physical activity education booklet, use of an accelerometer, and weekly check-in calls. No power training or motivational coaching will be delivered.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,573 Total Patients Enrolled

Devika Nair, MDPrincipal InvestigatorTennessee Valley Healthcare System Nashville Campus, Nashville, TN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still any opportunities to participate in this clinical trial?

"According to clinicaltrials.gov, this experimental trial is not currently accepting any more participants; the listing was first created on April 1st 2024 and revised lastly on October 12th 2023. Nonetheless, 532 other trials are actively recruiting patients as of now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pro-social Power Training Activity for Aging and Well-being With Chronic Kidney Disease

2025. "Pro-social Power Training Activity for Aging and Well-being With Chronic Kidney Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06089057.

All > Chronic Kidney Disease